<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1302">
  <stage>Registered</stage>
  <submitdate>20/05/2006</submitdate>
  <approvaldate>26/05/2006</approvaldate>
  <actrnumber>ACTRN12606000196549</actrnumber>
  <trial_identification>
    <studytitle>The efficacy of two alternative suture anchors, Panalok and bioraptor 2.3 for primary stabilisation of the shoulder for instability and identification of risk factors for recurrence of the shoulder instability post operation</studytitle>
    <scientifictitle>The efficacy of 2 alternative suture materials Ethibond and Panacryl used with Panalok 'suture anchors' for the primary open surgical stabilisation of the shoulder for instability - a double blind randomised trial</scientifictitle>
    <utrn />
    <trialacronym>Anchor stabilisation study</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Shoulder stabilisation: shoulder instability episodes not controlled with conservative measures</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Use of Panalok suture anchors with either a bioabsorbable suture (panacryl) or non- absorbable suture (ethibond) used during open surgical stabilisation of the shoulder for instability.</interventions>
    <comparator>Use of Panalok suture anchors with either a bioabsorbable suture (panacryl) or non- absorbable suture (ethibond) used during open surgical stabilisation of the shoulder for instability</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Our hypothesis is that there is no difference in outcome between panacryl and ethibond suture material when used for this procedure in which case the panacryl may be theoretically better as it dissolves away completely.</outcome>
      <timepoint>This is assessed at 2 weeks, 12 weeks, 6 , 12 and 24 months.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Identification of risk factors for recurrent instability post operatively.</outcome>
      <timepoint>Assesed at 12 and 24 months post operation.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Informed consent. Requiring anterior shoulder stabilisation.</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Previous stabilisation surgery to this shoulder.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Computer generated</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>30/05/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>236</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <postcode>3186 - Brighton</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Simon BELL</primarysponsorname>
    <primarysponsoraddress>A/Professor Simon Bell
Melbourne Shoulder and Elbow Centre
31 Normanby St.,
Brighton 3186</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>A/Professor Simon Bell, FRCS,FRACS,FAOrthA, PhD</fundingname>
      <fundingaddress>Melbourne Shoulder and Elbow Centre,
31 Normanby St., Brighton 3186 Vic, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>DePuy- Mitek</fundingname>
      <fundingaddress>P.O Box 476, Mt. Waverley 3149</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Smith and Nephew Surgical</fundingname>
      <fundingaddress>29 Essex St., Pascoe Vale 3044</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>During stabilisation of the shoulder which has been unstable (dislocated) the surgeon attaches back the damaged ligament to the bone with a 'Panalok" suture anchor. This is tied into place with a separate suture made of either panacryl which dissolves or ethibond which does not. The hypothesis is that there is no differenvce between the sutures but the bioabsorbable (dissolving) suture theoretically should be preferred because is disolves away completed and reduces the risk of foreign body reactions.
The sutures are dyed the same colour so the surgeon, the patient , the ward staff and outcome assessors are blinded</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Mercy aged and Health Care and Monash University HREC</ethicname>
      <ethicaddress />
      <ethicapprovaldate>22/05/2006</ethicapprovaldate>
      <hrec>R06/06P and CF10/0376</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Simon Bell</name>
      <address>Melbourne Shoulder and Elbow Centre
31 Normanby St.
Brighton VIC 3186</address>
      <phone>+61 3 95923775</phone>
      <fax>+61 3 95921486</fax>
      <email>coghlan@bigpond.net.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Jennifer Coghlan</name>
      <address>Monash University Dept. of Surgery
Melbourne Shoulder and Elbow Centre,
31 Normanby St.
Brighton VIC 3186</address>
      <phone>+61 3 95928028</phone>
      <fax>+61 3 95929612</fax>
      <email>coghlan@bigpond.net au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Simon Bell</name>
      <address>Monash University Dept. of Surgery
Melbourne Shoulder and Elbow Centre,
31 Normanby St.
Brighton VIC 3186</address>
      <phone>+ 61 3 95923775</phone>
      <fax />
      <email>coghlan@bigpond.net.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>